What We're Reading: Page 329
Industry reads hand-picked by our editors
Sep 02, 2016
-
Endpoints
Novartis’ retreat on CAR-T includes axing most of its senior execs on the team
-
Washington Post
For a 6-year-old with cancer, a future staked on medicine’s hottest field
-
New York Times
Hillary Clinton to unveil plan to address 'excessive' increases in drug prices
-
Reuters
What do patients know about generic biotech drugs?
Sep 01, 2016
-
Wall Street Journal
EpiPen Maker Mylan Tied Executive Pay to Aggressive Profit Targets
-
Financial Times
Biogen predicts preventive drug for Alzheimer's disease
-
San Diego Tribune
UCSD Nobel laureate Roger Tsien dies
-
Stat
Long Island county sues opioid drug makers for misleading marketing
Aug 31, 2016
Aug 30, 2016
Aug 29, 2016
Aug 26, 2016
-
Reuters
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
-
USA Today
Mylan isn't alone: 11 drugmakers with off-the-charts pricing power
-
The Hill
FDA: All blood donations should be tested for Zika
-
Wall Street Journal
Sen. Joe Manchin, Father of Mylan’s CEO, Airs ‘Concerns’ About Drug Costs
Previous
